XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance, beginning of period at Dec. 30, 2018   $ 0.0        
Redeemable Noncontrolling Interest            
Net income (loss)   0.1        
Changes in noncontrolling interest   14.9        
Balance, end of period at Dec. 29, 2019   15.0        
Balance, beginning of period (in shares) at Dec. 30, 2018     103,800,000      
Balance, beginning of period at Dec. 30, 2018 $ 519.3   $ 0.0 $ 1,244.5 $ (0.7) $ (724.5)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 11.0     11.0    
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)     800,000      
Issuance of common stock for employee stock purchase plan, options and warrants 4.9     4.9    
Restricted stock issued and related taxes (in shares)     200,000      
Restricted stock issued and related taxes (0.9)     (0.9)    
Issuance of common stock for acquisitions (in shares)     1,800,000      
Issuance of common stock for acquisitions 27.0     27.0    
Net income (loss) 12.5         12.5
Other comprehensive income (loss), net of tax 0.3       0.3  
Balance, end of period (in shares) at Dec. 29, 2019     106,600,000      
Balance, end of period at Dec. 29, 2019 574.1   $ 0.0 1,286.5 (0.4) (712.0)
Redeemable Noncontrolling Interest            
Net income (loss)   (0.2)        
Balance, end of period at Dec. 27, 2020   14.8        
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 21.0     21.0    
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)     400,000      
Issuance of common stock for employee stock purchase plan, options and warrants 4.8     4.8    
Restricted stock issued and related taxes (in shares)     200,000      
Restricted stock issued and related taxes (1.4)     (1.4)    
Issuance of common stock (in shares)     15,800,000      
Issuance of common stock 245.4     245.4    
Net income (loss) 79.6         79.6
Other comprehensive income (loss), net of tax $ 1.8       1.8  
Balance, end of period (in shares) at Dec. 27, 2020 123,047,147   123,000,000.0      
Balance, end of period at Dec. 27, 2020 $ 925.3   $ 0.0 1,556.3 1.4 (632.4)
Redeemable Noncontrolling Interest            
Net income (loss)   0.4        
Balance, end of period at Dec. 26, 2021   $ 15.2        
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 25.8     25.8    
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)     400,000      
Issuance of common stock for employee stock purchase plan, options and warrants 5.9     5.9    
Restricted stock issued and related taxes (in shares)     600,000      
Restricted stock issued and related taxes (9.1)     (9.1)    
Net income (loss) (2.0)         (2.0)
Other comprehensive income (loss), net of tax $ (0.8)       (0.8)  
Balance, end of period (in shares) at Dec. 26, 2021 123,987,424   124,000,000.0      
Balance, end of period at Dec. 26, 2021 $ 945.1   $ 0.0 $ 1,578.9 $ 0.6 $ (634.4)